Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York.
Division of Cardiovascular Medicine, University of California, San Diego, San Diego, California.
J Am Coll Cardiol. 2019 Nov 26;74(21):2607-2620. doi: 10.1016/j.jacc.2019.08.1064.
Risk factors for post-operative conduction disturbances after cardiac valve surgery requiring a permanent pacemaker (PPM) are poorly characterized.
The aim of this study was to investigate the timing and risk factors for PPM implantation after mitral or aortic valve surgery.
All patients who underwent open aortic or mitral valve surgery between January 1996 and December 2014 were reviewed using New York State's mandatory hospital discharge database. Patients with prior cardiac surgery or pre-existing PPM were excluded. The primary endpoint was PPM implantation within 1 year.
Among 77,882 patients, 63.8% (n = 49,706) underwent aortic valve replacement (AVR), 18.9% (n = 14,686) underwent mitral valve replacement (MVR), 10.5% (n = 8,219) underwent mitral valve repair (MVr), 5.4% (n = 4,202) underwent AVR plus MVR, and 1.4% (n = 1,069) underwent AVR plus MVr. The 1-year PPM implantation rate was 4.5% after MVr, 6.6% after AVR, 9.3% after AVR plus MVr, 10.5% after MVR, and 13.3% after AVR plus MVR (p < 0.001). Across all groups, the majority of PPMs were implanted during the index hospitalization (79.9%). MVr was associated with the lowest risk for PPM and AVR plus MVR with the highest risk. Older age, history of arrhythmias, pre-operative conduction disturbances, and concomitant index procedures were associated with increased risk for PPM during the index hospitalization. Conversely, beyond 30 days, chronic comorbidities were associated with increased risk for PPM.
Conduction disturbances requiring PPM remain a common adverse event after valve surgery. Identifying patients at risk for PPM will help facilitate perioperative planning and inform clinical decision making regarding post-operative rhythm surveillance.
心脏瓣膜手术后需要永久性起搏器(PPM)的术后传导障碍的风险因素描述不足。
本研究旨在探讨二尖瓣或主动脉瓣手术后 PPM 植入的时机和风险因素。
使用纽约州强制性医院出院数据库回顾 1996 年 1 月至 2014 年 12 月期间接受开放式主动脉或二尖瓣瓣膜手术的所有患者。排除既往心脏手术或预先存在 PPM 的患者。主要终点是 1 年内植入 PPM。
在 77882 例患者中,63.8%(n=49706)行主动脉瓣置换术(AVR),18.9%(n=14686)行二尖瓣置换术(MVR),10.5%(n=8219)行二尖瓣修复术(MVr),5.4%(n=4202)行 AVR 加 MVR,1.4%(n=1069)行 AVR 加 MVr。MVr 后 1 年 PPM 植入率为 4.5%,AVR 后为 6.6%,AVR 加 MVr 后为 9.3%,MVR 后为 10.5%,AVR 加 MVR 后为 13.3%(p<0.001)。在所有组中,大多数 PPM 都是在索引住院期间植入的(79.9%)。MVr 风险最低,AVR 加 MVR 风险最高。年龄较大、心律失常史、术前传导障碍和同时进行的指数手术与索引住院期间 PPM 风险增加相关。相反,超过 30 天后,慢性合并症与 PPM 风险增加相关。
传导障碍需要 PPM 仍然是瓣膜手术后的常见不良事件。确定需要 PPM 的患者将有助于促进围手术期计划,并为术后节律监测提供临床决策依据。